OneMedNet (NASDAQ:ONMD) CEO Buys $20,890.50 in Stock

OneMedNet Corporation (NASDAQ:ONMD) CEO Aaron Green bought 36,650 shares of the stock in a transaction that occurred on Tuesday, June 23rd. The shares were bought at an average cost of $0.57 per share, with a total value of $20,890.50. Following the completion of the transaction, the chief executive officer owned 1,896,375 shares in the company, valued at $1,080,933.75. The trade was a 1.97% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website.

Aaron Green also recently made the following trade(s):

• On Monday, June 15th, Aaron Green bought 18,702 shares of OneMedNet stock. The shares were bought at an average cost of $0.54 per share, for a total transaction of $10,099.08.
• On Friday, June 12th, Aaron Green purchased 36,920 shares of OneMedNet stock. The stock was bought at an average price of $0.56 per share, for a total transaction of $20,675.20.

OneMedNet Trading Up 7.4%

Shares of ONMD stock opened at $0.60 on Wednesday. The stock has a market cap of $32.66 million, a price-to-earnings ratio of -12.00 and a beta of 1.12. The stock has a 50-day moving average of $0.83 and a 200-day moving average of $0.92. OneMedNet Corporation has a 1-year low of $0.44 and a 1-year high of $4.22.

OneMedNet (NASDAQ:ONMD) last issued its quarterly earnings data on Friday, May 15th. The company reported ($0.04) earnings per share (EPS) for the quarter. The firm had revenue of $0.10 million during the quarter.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on ONMD. Weiss Ratings restated a “sell (e+)” rating on shares of OneMedNet in a research report on Monday, June 1st. Wall Street Zen cut shares of OneMedNet from a “hold” rating to a “sell” rating in a research report on Saturday, May 23rd. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, OneMedNet presently has a consensus rating of “Sell”.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Exencial Wealth Advisors LLC grew its stake in OneMedNet by 1.3% during the fourth quarter. Exencial Wealth Advisors LLC now owns 3,644,861 shares of the company’s stock worth $4,009,000 after purchasing an additional 45,401 shares during the period. HRT Financial LP bought a new stake in OneMedNet in the fourth quarter worth approximately $32,000. Jane Street Group LLC acquired a new position in OneMedNet in the fourth quarter valued at approximately $119,000. State Street Corp lifted its stake in OneMedNet by 41.5% in the fourth quarter. State Street Corp now owns 116,700 shares of the company’s stock valued at $128,000 after buying an additional 34,200 shares during the period. Finally, Virtu Financial LLC bought a new position in shares of OneMedNet during the 4th quarter worth approximately $48,000. 0.95% of the stock is owned by institutional investors and hedge funds.

OneMedNet Company Profile

OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences. OneMedNet Corporation is based in Eden Prairie, Minnesota.